Your shopping cart is currently empty

COG-1410 acetate is an apolipoprotein E-derived peptide and can be used in studies about neurological diseases.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $113 | - | In Stock | |
| 5 mg | $297 | - | In Stock | |
| 10 mg | $497 | - | In Stock | |
| 25 mg | $793 | - | In Stock | |
| 50 mg | $1,130 | - | In Stock | |
| 100 mg | $1,520 | - | In Stock | |
| 500 mg | $2,970 | - | In Stock |
| Description | COG-1410 acetate is an apolipoprotein E-derived peptide and can be used in studies about neurological diseases. |
| In vitro | In BV2 microglia cells, COG-1410 acetate (1-25 μM; 48 h) decreases the production and release of NO and TNFα[3]. |
| In vivo | COG-1410 acetate (0.8 mg/kg; i.v.) improves vestibulomotor function, and decreases poststroke locomotor asymmetry, and infarct volume of the ipsilateral hemisphere in rats[1]. COG-1410 acetate (0.3-0.6 mg/kg; i.v.) exhibits significant improvement on a short-term test of vestibulomotor function and on a long-term test of spatial learning and memory in mice[3]. |
| Synonyms | COG-1410 acetate(878009-24-6 Free base) |
| Molecular Weight | 1468.83 |
| Formula | C66H125N21O16 |
| Smiles | CC(O)=O.CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)[C@H](CCCCN)NC(=O)C(C)(C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)[C@H](CC(C)C)NC(=O)C(C)(C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(C)=O)C(N)=O |
| Sequence | Ala-Ser-Aib-Leu-Arg-Lys-Leu-Aib-Lys-Arg-Leu-Leu |
| Sequence Short | ASXLRKLXKRLL |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 146.88 mg/mL (100 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
H2O
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.